Clorox stock placed on JPM Negative Catalyst Watch amid worsening trends

Published 10/10/2025, 13:54
Clorox stock placed on JPM Negative Catalyst Watch amid worsening trends

Investing.com - JPMorgan Chase has placed Clorox (NYSE:CLX) on its Negative Catalyst Watch list, citing deteriorating channel trends that could impact the company’s financial performance. The stock, currently trading near its 52-week low at $120, has declined 24% year-to-date, though InvestingPro analysis suggests the shares are slightly undervalued.

The investment bank expects Clorox to deliver results at the bottom of its top-line guidance range, projecting a 19% decline excluding the Vitamins, Minerals and Supplements (VMS) segment. This weakness could lead to significant earnings per share deleverage in the upcoming quarter.

JPMorgan now forecasts first-quarter earnings per share of $0.60 for Clorox, substantially below the consensus estimate of $0.90. The firm indicated it "would not be surprised" if management reduces its outlook for fiscal year 2026.

Despite the near-term concerns, JPMorgan maintained its Neutral rating on Clorox stock, characterizing current challenges as "near-term hiccups" rather than fundamental problems with the business.

The investment bank remains optimistic about Clorox’s longer-term prospects, noting the company should benefit from its recent IT system overhaul, improved productivity initiatives, and multi-year innovation platforms.

In other recent news, Clorox Company reported its fourth-quarter and full-year 2025 earnings, significantly exceeding expectations. The company achieved an earnings per share (EPS) of $2.87, surpassing the forecasted $2.21, marking a surprise of nearly 30%. Additionally, Clorox’s revenue reached $2 billion, outperforming the anticipated $1.94 billion. In analyst updates, TD Cowen adjusted its price target for Clorox to $117, citing service disruptions during the company’s ERP system transition and ongoing weakness in organic sales growth. Conversely, Jefferies maintained a Buy rating with a $155 price target, noting that Clorox has moved beyond the initial challenges of the ERP rollout. In product news, Clorox introduced Clorox Screen+ Sanitizing Wipes, designed to clean and sanitize electronic devices. These wipes aim to address concerns about germs on shared devices in various settings. These developments provide a comprehensive view of Clorox’s recent activities and financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.